genXone S.A. (WSE:GX1)

Market Cap	20.09M
Revenue (ttm)	1.89M
Net Income (ttm)	-3.79M
Shares Out	3.30M
EPS (ttm)	-1.15
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2
Average Volume	1,064
Open	6.00
Previous Close	5.90
Day's Range	6.00 - 6.00
52-Week Range	4.64 - 8.48
Beta	-0.80
RSI	56.53
Earnings Date	Aug 11, 2025

About genXone

genXone S.A. operates in the biotechnology industry in Poland and internationally. The company operates in the field of molecular genetics and bioinformatics. It offers nucleic acid sequencing services based on nanopore sequencing technology. The company develops solutions in the form of laboratory protocols, as well as bioinformatics tools, scripts, and algorithms enabling the use of nanopore sequencing in various areas of science and business, including genetic diagnostics, food industry, veterinary medicine, and agriculture. genXone S.A. is ...

• Industry: Pharmaceuticals
• Sector: Healthcare
• CEO: Michal Kaszuba
• Employees: 16
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: GX1

Financial Performance

In 2024, genXone's revenue was 1.79 million, a decrease of -25.33% compared to the previous year's 2.39 million. Losses were -3.93 million, 5.58% more than in 2023.